"A University of Alberta biotechnology spinoff wants to put Edmonton at the epicentre of molecular discoveries by creating an immense searchable database that could speed up and drive down the cost of research and development." Click here for the full article in the Edmonton Journal.
The Alberta Glycomics Centre is proud to support the launch of biotech spin-off company 48Hour Discovery Inc., an Alberta-based company providing services in ligand discovery in unprecedented turnaround time and within a fully manageable costing model. Founded in February 2017, 48HD's core business is rooted in a proprietary molecular discovery platform emanating from the expertise and intellectual property generated from the Derda Research Group under the AGC research and commercialization umbrella. The company provides rapid ligand discovery services for any target using its expansive portfolio of genetically-encoded molecules, mining technology, and a standardized discovery protocol. More to follow on this… read more >>
AGC Director Dr. John Klassen's co-authored article "Investigating the Influence of Membrane Composition on Protein-Glycolipid Binding Using Nanodiscs and Proxy Ligand ESI-MS" has been accepted for publication in Analytical Chemistry. Watch this site for updates and links.
AGC Director Dr. John Klassen's co-authored article "High Throughput, Label- and Immobilization-Free Screening of Human Milk Oligosaccharides Against Lectins" has been accepted for publication in Analytical Chemistry. Watch this site for updates and links.
Essential reading: Esther Landhuis's "Sweet Success: Biologists are diving into sugar-molecule research thanks to new tools and techniques" in Nature 547 (06 July 2017), pp.127-9.
Twelve Alberta biotechnology and health sciences organizations joined Economic Development and Trade Minister Deron Bilous at the Biotechnology Innovation Organization’s (BIO) annual conference in San Diego this week. During the conference the minister secured more than $5.4 million in funding partnerships to give Alberta health researchers, innovators and entrepreneurs the opportunity to work alongside world-leading health industry experts to turn Alberta discoveries into businesses with products for the global market. Click here for the full press release from Economic Development and Trade.
The AGC is pleased to announce that Dr. Matt Macauley will be joining our team as a primary investigator commencing August 2017. An outstanding young carbohydrate chemist, Dr. Macauley has been an Assistant Professor of Chemical Physiology at The Scripps Research Institute in La Jolla, California since 2014, following a distinguished graduate career at Simon Fraser University.